Fusion Antibodies (LON:FAB) Stock Price Down 4.2% – Here’s Why

Fusion Antibodies plc (LON:FAB)’s stock price fell 4.2% during mid-day trading on Monday . The company traded as low as GBX 10.22 ($0.14) and last traded at GBX 10.84 ($0.14). 2,311,406 shares changed hands during trading, an increase of 123% from the average session volume of 1,036,140 shares. The stock had previously closed at GBX 11.32 ($0.15).

Fusion Antibodies Stock Down 4.2%

The stock has a 50 day simple moving average of GBX 7.32 and a 200-day simple moving average of GBX 7.28. The firm has a market cap of £10.20 million, a PE ratio of -2.44 and a beta of 0.49. The company has a debt-to-equity ratio of 2.40, a current ratio of 3.87 and a quick ratio of 2.36.

Fusion Antibodies Company Profile

Fusion is a Belfast based contract research organisation (“CRO”) providing a range of antibody engineering services for the development of antibodies for both therapeutic drug and diagnostic applications.

The Company’s ordinary shares were admitted to trading on AIM on 18 December 2017. Fusion provides a broad range of services in antibody generation, development, production, characterisation and optimisation.